Department of Surgery, SB Okmeydanı Training and Research Hospital, İstanbul, Turkey.
Department of Surgery, Bayındır Levent Hospital, İstanbul, Turkey.
Int J Surg. 2014 Dec;12(12):1324-7. doi: 10.1016/j.ijsu.2014.10.038. Epub 2014 Nov 1.
To investigate the prognostic significance of the number of lymph nodes removed in colorectal cancer (CRC) patients with no metastatic lymph node.
The clinicopathological data of 461 CRC patients was analyzed. In order to compare the survival of patients who had fewer lymph nodes removed versus the survival of patients who had 1-3 metastatic lymph node(s), a separate group of 74 N1 disease patients were also included in the study. All patient data were collected prospectively. Kaplan-Meier method was used for calculation and plotting of the survival curves of the patient groups, and log-rank test was used for the comparison of the survival curves.
Cancer-specific survival (CSS) rates of patients who had 1-7 lymph node(s) and 8-11 lymph nodes removed were significantly worse than those who had 12 or more lymph nodes removed (p = 0.006 and p = 0.037, respectively), while CSS was not significantly different between those who had 1-7 versus 8-11 lymph node(s) removed (p = 0.647); this grouping had independent prognostic significance in Cox analysis (p = 0.006). CSS of patients with N1 disease was not significantly different from those who had 1-7 and 8-11 lymph node(s) removed (p = 0.312 and p = 0.165, respectively), while it was significantly worse than CSS of patients who had 12 or more lymph nodes removed (p = 0.001).
In colorectal cancer patients whose removed lymph nodes are non-metastatic, removal of at least 12 lymph nodes will determine the lymph node status reliably.
为了研究无转移性淋巴结的结直肠癌(CRC)患者切除的淋巴结数量的预后意义。
分析了 461 例 CRC 患者的临床病理资料。为了比较切除淋巴结较少的患者与切除 1-3 个转移性淋巴结的患者的生存情况,本研究还纳入了另一组 74 例 N1 疾病患者。所有患者数据均为前瞻性收集。采用 Kaplan-Meier 法计算并绘制患者组的生存曲线,对数秩检验比较生存曲线。
切除 1-7 个和 8-11 个淋巴结的患者的癌症特异性生存率(CSS)明显低于切除 12 个或更多淋巴结的患者(p=0.006 和 p=0.037),而切除 1-7 个与 8-11 个淋巴结的患者 CSS 无明显差异(p=0.647);该分组在 Cox 分析中具有独立的预后意义(p=0.006)。N1 疾病患者的 CSS 与切除 1-7 个和 8-11 个淋巴结的患者无明显差异(p=0.312 和 p=0.165),但明显低于切除 12 个或更多淋巴结的患者(p=0.001)。
在无转移性淋巴结的结直肠癌患者中,至少切除 12 个淋巴结可以可靠地确定淋巴结状态。